EXCLUSIVE: Vivani Medical Tells Benzinga 'Vivani's GLP-1 (Exenatide) Implant Produced Sham-implant Adjusted Liver Fat Reduction of 82% in an Obese Mouse Model From a Single Administration With Expected Twice-yearly Dosing'
EXCLUSIVE: Vivani Medical Tells Benzinga 'Vivani's GLP-1 (Exenatide) Implant Produced Sham-implant Adjusted Liver Fat Reduction of 82% in an Obese Mouse Model From a Single Administration With Expected Twice-yearly Dosing'
獨家消息：Vivani Medical告訴Benzinga，Vivani的GLP-1（Exenatide）植入物在一個肥胖小鼠模型中通過一次給藥產生假植入物調整後的肝臟脂肪降低82％，預期每年兩次給藥。
EXCLUSIVE: Vivani Medical Tells Benzinga 'Vivani's GLP-1 (Exenatide) Implant Produced Sham-implant Adjusted Liver Fat Reduction of 82% in an Obese Mouse Model From a Single Administration With Expected Twice-yearly Dosing'
獨家消息：Vivani Medical告訴Benzinga，Vivani的GLP-1（Exenatide）植入物在一個肥胖小鼠模型中通過一次給藥產生假植入物調整後的肝臟脂肪降低82％，預期每年兩次給藥。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。